Becton Dickinson BDX
NYSE BDX
$179.76 +1.71 (+0.96%)
As of: Sep 9, 2026 · 3:59 PM EDT

Becton Dickinson (BDX) Capital Expenditures (2009 - 2026)

Becton Dickinson's (BDX) quarterly Capital Expenditures came in at $143.0 million in Q2 2026, down 12.8% year-over-year from $164.0 million in Q2 2025, and up 14.4% quarter-over-quarter from $125.0 million in Q1 2026.

Analysis

Becton Dickinson (BDX) Capital Expenditures (2009 - 2026) Analysis & Trends

Becton Dickinson (BDX) has reported Capital Expenditures for 18 consecutive years, with $143.0 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Capital Expenditures fell 12.8% year-over-year to $143.0 million in Q2 2026; TTM through Jun 2026 was $753.0 million, a 10.9% increase from a year earlier, with the FY2025 full-year figure at $760.0 million, up 4.83% from the prior year.
  • Capital Expenditures was $143.0 million for Q2 2026 at Becton Dickinson, up from $125.0 million in the prior quarter.
  • Over five years, Capital Expenditures peaked at $377.0 million in Q3 2025 and troughed at $105.0 million in Q4 2024.
  • A 5-year average of $195.8 million and a median of $180.0 million in 2023 frame the typical range for Capital Expenditures.
  • Across the five-year window, Capital Expenditures slumped 44.23% in 2023 and climbed 27.36% in 2025, its largest moves.
  • Over 5 years, Capital Expenditures stood at $208.0 million in 2022, then tumbled by 44.23% to $116.0 million in 2023, then dropped by 9.48% to $105.0 million in 2024, then advanced by 2.86% to $108.0 million in 2025, then jumped by 32.41% to $143.0 million in 2026.
  • The last three Capital Expenditures figures came in at $143.0 million (Q2 2026), $125.0 million (Q1 2026), and $108.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Becton Dickinson 49.48 Bn 48.62 Bn 2.32 Bn 143.00 Mn
2 Medline 29.24 Bn 26.56 Bn 2.22 Bn 111.00 Mn
3 West Pharmaceutical Services 23.94 Bn 23.51 Bn 329.20 Mn 43.20 Mn
4 Baxter International 12.66 Bn 10.51 Bn 1.03 Bn 116.00 Mn
5 Stevanato Group S.p.A 5.51 Bn 5.40 Bn 100.91 Mn -67.01 Mn
6 Acme United 233.67 Mn 228.63 Mn 26.69 Mn 1.07 Mn
7 Rockwell Medical 31.87 Mn 7.07 Mn 3.24 Mn 617,000.00
8 Retractable Technologies 21.39 Mn -18.48 Mn 190,852.00 29,823.00
9 United Health Products 9.09 Mn 9.06 Mn - -
10 Cuprina Holdings (Cayman) 7.45 Mn 4.33 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 143.00 Mn
Mar 31, 2026 125.00 Mn
Dec 31, 2025 108.00 Mn
Sep 30, 2025 377.00 Mn
Jun 30, 2025 164.00 Mn
Mar 31, 2025 114.00 Mn
Dec 31, 2024 105.00 Mn
Sep 30, 2024 296.00 Mn
Jun 30, 2024 179.00 Mn
Mar 31, 2024 134.00 Mn
Dec 31, 2023 116.00 Mn
Sep 30, 2023 294.00 Mn
Jun 30, 2023 191.00 Mn
Mar 31, 2023 181.00 Mn
Dec 31, 2022 208.00 Mn
Sep 30, 2022 315.00 Mn
Jun 30, 2022 253.00 Mn
Mar 31, 2022 222.00 Mn
Dec 31, 2021 183.00 Mn
Sep 30, 2021 452.00 Mn